Sonos Inc (SONO)
Return on equity (ROE)
| Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | -38,146 | -16,292 | -43,572 | -4,515 | -10,274 | -43,102 | -20,128 | 19,090 | 67,383 | 122,706 | 141,129 | 149,784 | 158,595 | 185,750 | 110,944 | 41,403 | -20,114 | -68,125 | -25,154 | 4,342 |
| Total stockholders’ equity | US$ in thousands | 428,620 | 464,391 | 494,004 | 594,409 | 518,657 | 590,210 | 612,914 | 633,354 | 560,513 | 642,736 | 671,684 | 679,607 | 569,042 | 587,127 | 579,268 | 510,209 | 297,839 | 261,199 | 299,804 | 367,279 |
| ROE | -8.90% | -3.51% | -8.82% | -0.76% | -1.98% | -7.30% | -3.28% | 3.01% | 12.02% | 19.09% | 21.01% | 22.04% | 27.87% | 31.64% | 19.15% | 8.11% | -6.75% | -26.08% | -8.39% | 1.18% |
September 30, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $-38,146K ÷ $428,620K
= -8.90%
Sonos Inc's return on equity (ROE) has shown fluctuating performance over the past several quarters. The ROE has ranged from as low as -26.08% in December 2019 to as high as 31.64% in June 2021.
In the most recent quarter, ending September 30, 2024, the ROE was -8.90%, indicating a negative return on equity. This suggests that Sonos Inc generated a net loss relative to its shareholder equity during this period.
The trend in ROE indicates that Sonos Inc has experienced challenges in generating profits in recent quarters, as shown by the negative or low ROE figures. It is essential for the company to closely monitor and address the factors contributing to these fluctuations in ROE to enhance profitability and create value for its shareholders.
Overall, the analysis of Sonos Inc's ROE highlights the importance of consistent performance and efficient management of assets and liabilities to maximize shareholder value over time.
Peer comparison
Sep 30, 2024